Serum MiRNA-23a as a Diagnostic and Prognostic Biomarker of Hepatitis C Related Hepatocellular Carcinoma

Serum miR-26a-5p and miR-199b-5p as a biomarker to predict therapy for Diffuse Large B-cell lymphoma with Hepatitis C Infection

Study of MiRNA-155 Gene Expression in Egyptian Patients with Gene Expression in Egyptian Patients with Chronic Hepatitis C Viral infection

Associations of MicroRNA-34a Expression Profile; Serum Levels of Vascular Endothelial Growth Factor and Disease Progression in Hepatitis C Patients

MicroRNA 122 as adiagnostic biomarker for hepatitis C- related hepatocellular carcinoma

MicroRNA-15a expression level and its target “c-Myb” expression in Hepatocellular carcinoma Among Chronic HCV Egyptian Patients

Assessment of the Level of Soluble CD25 as a Marker for the Detection of Hepatocellular Carcinoma in Chronic Hepatitis C virus (HCV) Infected Patients

Serum mir-30e and mir-223 as novel noninvasive biomarkers for hepatocellular carcinoma

miR-203 and endocan as diagnostic markers for hepatocellular carcinoma related viral infections

Clinical significance of LncRNA-MIAT as a non-invasive diagnostic marker of non-Hodgkin's lymphoma associated with occult hepatitis C virus infection